Financial

Vesper Medical Completes $10.5 M Series A Financing to Drive Development of Next Generation Venous Stents

WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it completed its Series A financing totaling $10.5 million. Major participants in the Series A financing included New Enterprise Associates and Quaker Partners. The financing occurred in two tranches and is […]

Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule

VANCOUVER, May 10, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, announced today that it has received written notification (the “Nasdaq Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has […]

Corindus Reports First Quarter 2018 Results

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2018. Recent Highlights and Accomplishments Realized revenue of $1.5 million in the first quarter 2018 Increased CorPath® GRX installed base to 37 systems with […]

Zynex Announces 2018 First Quarter Earnings

ENGLEWOOD, Colo., May 8, 2018 /PRNewswire/ — Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2018. President and CEO […]

BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance

FRANKLIN LAKES, N.J., May 3, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.222 billion for the second fiscal quarter ended March 31, 2018.  This represents an increase of 42.2 percent from the prior-year period, which is primarily due to the acquisition […]

Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year

DANVERS, Mass., May 03, 2018 — ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported fourth quarter fiscal 2018 revenue of $174.4 million, an increase of 40% compared to revenue of $124.7 million for the same period of fiscal 2017.  For fiscal year 2018, total revenue […]

LivaNova Reports First Quarter 2018 Results

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2018. For the first quarter of 2018, worldwide sales from continuing operations were $250.4 million, an increase of 10.4 percent on a reported basis and an increase […]